BridgeMD
New treatment option for Hoarding Disorder
Official title Rapid Non-Invasive Brain Stimulation for Hoarding Disorder
ClinicalTrials.gov ID: NCT06712914
What this study is testing
- What it's testing
- This study explores whether rapid non-invasive brain stimulation can help reduce hoarding disorder symptoms.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age 18-70 years
- Primary diagnosis of hoarding disorder
- Sufficient severity of hoarding symptoms
- Willing and able to understand and complete consent and study procedures
You likely can't join if
- Psychiatric or medical conditions or medications that make participation unsafe
- Pregnant or nursing females
- Previous exposure to TMS or ECT
- History of any implanted device or psychosurgery
The study team makes the final eligibility decision.
Where it's taking place
- Palo Alto, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Palo Alto, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.